Latest News

 

Spotlight

 

Technology

05-20-13 Zogenix and Battelle to Present Positive, New Data Demonstrating Value of Needle-Free Injection for Biologics
05-09-13 Zogenix Reports First Quarter 2013 Financial Results
05-03-13 Zogenix Announces Conference Call and Webcast to Present First Quarter 2013 Financial Results

  Our lead investigational product, Zohydro ER™, if approved by the FDA, could be the first hydrocodone product to offer the benefit of less frequent dosing and the ability to treat chronic pain patients without the risk of acetaminophen-related liver injury.

  DosePro is a first-in-class, easy-to-use drug delivery system designed for self-administration of a pre-filled, single dose of liquid drug, subcutaneously, without a needle. DosePro offers benefits to patients including instant, easy dosing, less anxiety over self-injection, no need for sharps disposal, no risk of needle stick injury or contamination, and reliable performance.